CHSCPNasdaqWholesale-Farm Product Raw MaterialsFiscal year ends August 31Also trades as CHSCL, CHSCM, CHSCN, CHSCO
CHS INC
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 8, 2026
$25.65−0.08 (-0.31%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
3.2%−0.3 pts over 5 years
Operating margin
0.3%−0.7 pts over 5 years
Net margin
1.7%+0.2 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -9.7% | -9.5% | +4.5% | +0.3% | |
| Gross profit | -35.1% | -18.8% | +3.0% | -2.7% | |
| Operating income | -84.5% | -56.8% | -20.0% | -18.7% | |
| Net income | -45.8% | -29.1% | +7.2% | -2.6% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 4.9% | 4.9% | 5.5% | |
| Return on assets | 2.4% | 2.6% | 3.2% | |
| Current ratio | 1.06 | 1.27 | 1.53 | |
| Debt to equity | 0.29 | 0.20 | 0.17 | |
| Net debt to EBITDA | 2.64× | 2.09× | 2.03× | |
| Interest coverage | 2.6× | 2.4× | 0.6× | |
| Inventory turnover | 11.7× | 9.8× | 10.8× | |
| Capex to revenue | 2.3% | 1.5% | 2.1% |
Where the cash went
Fiscal 2021 to 2025, five years combined
CHS generated $7.90B from operations and spent $2.77B on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$7.90B
Used
$2.77B
Capital expenditure$2.77B100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin1.7%
×Asset turnover1.89×
×Equity multiplier1.72×
=Return on equity, FY20255.5%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 1.7% | 1.89× | 1.72× | 5.5% |
| FY2024 | 2.8% | 2.08× | 1.78× | 10.4% |
| FY2023 | 4.2% | 2.41× | 1.90× | 19.1% |
| FY2022 | 3.5% | 2.63× | 1.97× | 18.2% |
| FY2021 | 1.4% | 2.29× | 1.88× | 6.2% |
| FY2020 | 1.5% | 1.75× | 1.86× | 4.9% |
| FY2019 | 2.6% | 1.94× | 1.96× | 9.9% |
| FY2018 | 2.4% | 2.03× | 2.03× | 9.8% |
| FY2017 | 0.2% | 1.93× | 2.13× | 0.9% |
| FY2016 | 1.3% | 1.87× | 2.10× | 4.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$597.92M
- Cash generatingOperating cash flow above zero$635.79M
- Return on assets improvedROA up on the prior year5.8% → 3.2%
- Earnings backed by cashOperating cash flow above net income$635.79M vs $597.92M
- Less leverageLong-term debt to assets fell9.7% → 9.3%
- Better liquidityCurrent ratio rose1.61 → 1.53
- No dilutionShare count did not rise– → –
- Gross margin improvedGross margin up on the prior year4.46% → 3.21%
- More efficientAsset turnover rose2.07 → 1.89